On October 11th 2018 Flanders Vaccine is happy to host its third edition of “Immunity for Health”: the Flanders Vaccine annual flagship event where all stakeholders, both from the human and animal health sector, working in the field of immunology, vaccinology, immune-oncology and infectious diseases are invited to meet, interact and start collaborations.
The theme of this year’s edition is “Preventive Health Care“. We are honoured to welcome some renowned experts in the field and are looking forward to be inspired by their talks!
Venue: Park Inn Hotel, Martelarenlaan 36, 3010 Leuven, Belgium (< 5 minutes walking from the train station)
Rooms can be booked directly with the hotel (email: Park Inn Hotel, Tel: +32 (0)16 61 66 00). Please indicate that your booking is related to the event Immunity for Health. Room costs are not covered by the event.
REGISTRATION <<< click here >>>
This event is supported by sponsorship from:
MSD Belgium VIB GSK
GOLD SPONSOR: EVENT SPONSOR:
08:30 REGISTRATION and welcome coffee
09:30 OPENING KEYNOTE I : How cooperation on vaccination can strengthen crisis preparedness, preventive healthcare and sustainable use of antibiotics – perspective from the European Commission
Michael Sulzner, Policy Officer, Unit Crisis Management and Preparedness in Health, DG SANTE, European Commission
Part I: Clinical Trials Track – Preventive healthcare in Belgium
Chair: Geert Leroux-Roels, Professor Emeritus Ghent University
10:00 KEYNOTE II : Preventive healthcare policy: How can we stimulate participation in clinical trials
Diane Kleinermans, Advisor of Ministry of Social Affairs and Public Health
10:30 COFFEE BREAK
11:00 Talk I: Quarantine vaccine study to assess safety, immunogenicity and shedding of novel polio vaccines
Pierre Van Damme, Professor and head of Vaccine & Infectious Disease Institute, Antwerp University / vice-dean Faculty of Medicine and Health Sciences, Antwerp University / vice-chairman of the board of Flanders Vaccine
11:20 Talk II: Strengths of the Flemish Vaccination Programme
Geert Top, MD Vaccination Programme Manager, Flemish Agency for Care and Health & Corinne Vandermeulen, Professor KU Leuven and member of the board of Flanders Vaccine
11:40 Pitch session
1. Safety first: a phase I study with an unusual human RSV vaccine candidate (Prof. Xavier Saelens, VIB-UGent)
2. RABYD-VAX: A dual yellow fever/rabies vaccine launched from a plasmid (Phd Lotte Coelmont, KU Leuven)
3. Pioneering Allergy Vaccines (Thierry Legon, ASIT Biotech)
Part II: R&D Track – Preventive healthcare for sustainable use of antibiotics
Chair: Adrian Wildfire, SGS (event sponsorship)
13:25 Introduction by SGS
13:30 KEYNOTE III: Antibiotic resistance in human and veterinary medicine: critical molecules and bacteria and how (novel) vaccines can help
Eric Cox, Professor of Immunology, Faculty of Veterinary Medicine, Ghent University & Fabiana Dal Pozzo, Coordinator of AMCRA
14:00 Talk III: Modulating the immune system to enable the sustainable use of antibiotics
Adam Cunningham, Professor of Functional Immunity, University of Birmingham, Co-Director of BactiVac, UK
14:30 Pitch session
1. Using the power of aggregation to develop novel antibiotics ( Els Beirnaert, Aelin Therapeutics)
2. Fast Assay for Pathogen Identification and Characterization (FAPIC project) (Prof. Inge Gyssens, Hasselt University & Radboud University Medical Center Nijmegen)
15:00 Talk IV: The pig as a model for translational research: Update on Flanders Vaccine’s first R&D Consortium
Hugo Van Heuverswyn, CEO Biomaric, member of the board of Flanders Vaccine
15:15 Talk V: Launch of a digital adjuvant to boost innovation and expand the Flanders Vaccine network
Arne Smolders, CEO AcademicLabs
15:30 COFFEE BREAK
Part III: Track Regional and International visibility – Preventive healthcare beyond the borders
Chair: Niels Hellings, member of the Board, Flanders Vaccine
16:00 Talk VI: I-REIVAC a French network dedicated to clinical vaccine research
Odile Launay, Head coordinator of the Cochin-Pasteur Clinical Research Centre, Paris, France
16:20 Talk VII: Cross-regional collaboration to combat antimicrobial resistance
Remko Van Leeuwen, Head Director of Acquisitions – AIGHD Foundation and Department of Global Health, the Netherlands
16:40 CLOSING KEYNOTE : Use of novel data sources to quantify the impact of influenza and promote vaccination among patients with diabetes
Rosalind Hollingsworth, PhD – Global Medical Expert Lead, Influenza/RSV & Global Medical Strategy, Sanofi Pasteur (DIAMOND SPONSOR)
17:10 MOOC: Vaccines: from smallpox to technologies of the future
Lotte Coelmont, Innovation Manager (IOF), KU Leuven, Laboratory of Virology and chemotherapy (Rega Institute)
17:20 CLOSING REMARKS
17:30 Networking reception
REGISTRATION – Deadline 4 October 2018
- Flanders Vaccine member: €70 (21% VAT excl.)
- Non-member: €120 (21% VAT excl.)
- Students: €50 (21% VAT excl.)
The conference registration fee covers your attendance at the conference, including welcome coffee, lunch, refreshments and reception.
FOR REGISTRATION click here.
Registration is open until October 4th 2018. Once registered, you will receive a confirmation email and within the following weeks an invoice will be sent to you. Please note that the invoice needs to be paid before the start of the event.
Notifications received upon 2 weeks before the start of the event, get refunded for 100%. Cancellation requests received less than 2 weeks before the start of the event won’t be refunded.
Replacement by a colleague is always allowed.
You can be part of the Immunity for Health community and enlarge your visibility by opting for one of our sponsorship packages.
Indicated prices are exclusive 21% VAT.
Please keep in mind that the number of available exhibition booths is limited.
For more information, contact Fran Van Heuverswyn: firstname.lastname@example.org.
* Announcement on display screen + on catering buffet